Resources

Knowledge Center
Filter
Blogs
Case Studies
Data
Factsheets
Govt. Strategies, Plans, and Documents
High-Impact Practices
Infographics
Meeting Documents
Newsletters
Presentations
Publications
Q&A
Remarks
Toolkits
Videos and Webinars
Website and Portals
Advocacy & Awareness
Beyond 2020
Contraceptive Security
ECHO Study
FP in Humanitarian Settings
Financing
Innovation
Policy and Enabling Environment
Rights
Service Delivery & Quality
Young People
Commitment Maker
Country
Commitment Maker
Country
Date: 11/18/2016
Source: PATH
Type: Newsletters
As access to Sayana® Press (subcutaneous depot medroxyprogesterone acetate, or DMPA-SC in Uniject™) expands globally, PATH has monitored product consumption in four pilot introduction countries: Burkina Faso, Niger, Senegal, and Uganda. As the introduction phase draws to a close and all four countries move toward scale-up, they are transitioning Sayana Press consumption data collection into...
Date: 11/16/2016
Source: PATH
Type: Case Studies
Self-injection of the contraceptive Sayana® Press is both feasible and highly acceptable among women participating in the first such research study conducted in sub-Saharan Africa, according to results published online by the journal Contraception. Sayana Press is an all-in-one injectable contraceptive that puts control of women's health in their hands. It is a subcutaneous formulation of the...
Date: 05/27/2016
Source: PATH
Type: Newsletters
Over 90,000 new contraceptive users reached       As access to Sayana Press expands globally, PATH has continued to monitor Sayana Press consumption in four pilot introduction countries: Burkina Faso, Niger, Senegal, and Uganda. PATH will continue to collect monitoring data from the pilot introductions through June 2016, approximately two years after the pilots launched. In the meantime, PATH...
Date: 05/26/2016
Source: PATH
Type: Website and Portals
About the product Sayana® Press is a three-month, progestin-only, all-in-one injectable contraceptive that combines the drug and needle in the Uniject™ injection system. Sayana Press is small, light, easy to use, and requires minimal training, making it especially suitable for community-based distribution—and for women to administer themselves through self-injection. Sayana Press can improve...
Date: 11/01/2015
Source: PATH
Type: Newsletters
Access to the contraceptive option Sayana® Press continues to expand worldwide. Between July 2014 and June 2015, approximately 6,500 health providers in Burkina Faso, Niger, Senegal, and Uganda were trained to administer Sayana Press and offer the product along with other methods in the context of informed choice. PATH and partners are monitoring the first four Sayana Press introductions in sub-...
Can we help you find something?
Advocacy & Awareness
Beyond 2020
Contraceptive Security
ECHO Study
FP in Humanitarian Settings
Financing
Innovation
Policy and Enabling Environment
Rights
Service Delivery & Quality
Young People
Commitment Maker
Country
Commitment Maker
Country